Alpha Profiles · Company Profile

Nuvation Bio Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/nuvation-bio-inc

Entity: Public listing published
Primary listing: NYSE: NUVB
Verification: Partially verified
Last reviewed: 2026-10-13T04:45:58.617162+00:00

Overview

Alpha's canonical identity and public leadership record for Nuvation Bio Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

13 public records

Colleen Sjogren

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

David Hanley

Chief Technical Operations Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

David Hung

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

David Hung, M.D.

President and Chief Executive Officer

State: confirmed
Effective: From Apr 10, 2026
Confidence: 94%
Evidence: NUVB DEF 14A executive officersApr 10, 2026

David Liu

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

Gary Hattersley

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

George Mclean Milne Jr., Ph.D.

Chief Scientific Officer

State: confirmed
Effective: From Apr 10, 2026
Confidence: 94%
Evidence: NUVB DEF 14A executive officersApr 10, 2026

Kerry Wentworth

Chief Regulatory Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

Moses Makunje

Vice President, Finance, Principal Accounting Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

Philippe Sauvage

Chief Financial Officer, Principal Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

Stacy Markel

Chief People Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

Stephen Dang

Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001140361-26-014157Apr 10, 2026

Stephen Dang, Ph.D.

Chief Legal Officer

State: confirmed
Effective: From Apr 10, 2026
Confidence: 94%
Evidence: NUVB DEF 14A executive officersApr 10, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.